- Biomedical Research Facility Opens At Georgia StateGeorgia State University has unveiled its newest state-of-the-art research facility, the Research Science Center, to support biomedical research. The $45 million building will house up to four principal investigators and their faculty and staff, as well as postdoctoral scholars, graduate students and undergraduate students. The center, constructed without the use of taxpayer funds, is at… more » The post Biomedical Research Facility Opens At Georgia State appeared first on Research.News
- Georgia State Sets Research Funding RecordGeorgia State University has set a research funding record, receiving awards of $120.2 million in fiscal year 2016. The total exceeds the previous record set last year when faculty earned $101 million in research support. Georgia State’s research funding has grown by nearly $40 million in the past two years. “The increase in research awards… more » The post Georgia State Sets Research Funding Record appeared first on Research.News
- Georgia State Funds Eight Faculty Proposals as Part of Next Generation InitiativeGeorgia State University will fund eight faculty proposals as part of its Next Generation faculty program, a successor to the Second Century Initiative, which has brought 61 new faculty positions to the university over the last five years. Funding for the proposals is expected to be about $2 million in the next year. … more » The post Georgia State Funds Eight Faculty Proposals as Part of Next Generation Initiative appeared first on Research.News
- Findings Offer Alternative Treatments of CancerResearchers have discovered gene-targets (biomarkers) that may enable alternative treatments or the potential design of new drugs that target metastasis-promoting tumor genes. This is the key finding in a study led by researchers from Georgia State University in collaboration with the University of Oklahoma College of Medicine and published in journal Oncotarget. The post Findings Offer Alternative Treatments of Cancer appeared first on Research.News
powered by RSS Just Better 1.4 plugin
About the Center for Molecular and Translational Medicine
The Center for Molecular and Translational Medicine at Georgia State University meets healthcare needs by converting significant research findings into diagnostic tools and medicines to improve the health of individuals. The center is designed to help millions of people suffering from heart disease, diabetes and other illnesses. The current research focus of the center is to dissect molecular insights of cardiovascular remodeling in obesity and obesity related diseases, including diabetes, hypertension, heart diseases, and stroke, with special emphasis on the regulation of these processes.
Ming-Hui Zou, an internationally recognized researcher in molecular and translational medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine and associate vice president for research at Georgia State University, is the founding director of the Center for Molecular and Translational Medicine at Georgia State.
An independent investigator of the National Institutes of Health, the Juvenile Diabetes Research Foundation International, and the American Diabetes Association, and a National Scientist Development and National Established Investigator awardee of the American Heart Association, Zou has used these (and many other awards) to make scientific observations in fields with great potential for immediate clinical relevance.Read more about Zou
We effectively transform information gained from biomedical research into knowledge improving the state of human health and disease.